Search - tctmd.com

Displaying 681 - 700 of 15157

Sort: Relevancy | Date

Presentation TCT 2016

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Presenter: Michael D. Dake, Kenneth Rosenfield, Mehdi H. Shishehbor

November 01, 2016

Presentation TCT 2016

Bayesian Statistics: Utility and Interpretation

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Marc Etienne Jolicoeur

November 01, 2016

Presentation TCT 2016

VIDEOTAPED CASE: Percutaneous EVAR Under Conscious Sedation: Demonstration of Technique and Tips

Presenter: D. Christopher Metzger, Peter A. Schneider

November 01, 2016

Presentation TCT 2016

Propensity-Matched Analysis: Advantages and Pitfalls

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Tracy Y. Wang

November 01, 2016

Presentation TCT 2016

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

Presenter: Ted Feldman, David Hildick-Smith, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Somjot S. Brar

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson

November 01, 2016

Presentation TCT 2016

Hypogastric Embolization Is No Longer Necessary in Aorto-iliac EVAR With Contemporary Devices and Techniques

Presenter: D. Christopher Metzger, Peter A. Schneider, Brian G. DeRubertis

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Subgroup Analyses: How Useful or Harmful Are They?

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Sanjay Kaul

November 01, 2016

Presentation TCT 2016

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

Presenter: D. Christopher Metzger, Peter A. Schneider, Ehrin J. Armstrong

November 01, 2016

Presentation TCT 2016

TCTMD Global PCI Map Project

Presenter: Ivan C. Rokos

October 31, 2016

Presentation TCT 2016

My Most Challenging Case 2016: STEMI with Multivessel Disease

Presenter: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu, Ning Guo

October 31, 2016

Presentation TCT 2016

Treatment of a Rare Complication in the 21st Century

Presenter: Wojtek Wojakowski, Balint Kittka

October 31, 2016

Presentation TCT 2016

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Presenter: Neil E. Moat, John G. Webb, Philippe Généreux

October 31, 2016

Advertisement

Results of the FIH Chocolate Touch Drug Coated Balloon Catheter for PAD: The ENDURE Trial

Bayesian Statistics: Utility and Interpretation

VIDEOTAPED CASE: Percutaneous EVAR Under Conscious Sedation: Demonstration of Technique and Tips

Propensity-Matched Analysis: Advantages and Pitfalls

Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial

Meta-analysis (Standard and Network): The Good, the Bad, and the Ugly

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve

Hypogastric Embolization Is No Longer Necessary in Aorto-iliac EVAR With Contemporary Devices and Techniques

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience

Subgroup Analyses: How Useful or Harmful Are They?

Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR

TCTMD Global PCI Map Project

My Most Challenging Case 2016: STEMI with Multivessel Disease

Treatment of a Rare Complication in the 21st Century

Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content